Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHORLEMMER, H. U")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 70

  • Page / 3
Export

Selection :

  • and

Development of a novel drug for transplantation : Current results and future perspectivesSCHORLEMMER, H. U.Transplantation proceedings. 2001, Vol 33, Num 3, pp 2425-2428, issn 0041-1345Conference Paper

Derivatives of leflunomide's active metabolite A77-1726, the malononitrilamides (mnas), prevent the development of experimental arthritisSCHORLEMMER, H. U; SCHLEYERBACH, R.International journal of immunotherapy. 1998, Vol 14, Num 4, pp 177-184, issn 0255-9625Article

Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survivalSCHORLEMMER, H. U; KURRLE, R.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4170-4173, issn 0041-1345Conference Paper

Control of mouse-to-rat skin xenograft rejection by malononitrilamidesSCHORLEMMER, H. U; KURRLE, R.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3037-3039, issn 0041-1345Conference Paper

Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamidesSCHORLEMMER, H. U; BARTLETT, R. R.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4153-4155, issn 0041-1345Conference Paper

Malononitrilamides (MNAs) in combination with cyclosporine synergistically prevent acute and treat ongoing skin allograft rejectionSCHORLEMMER, H. U; RUUTH, E; KURRLE, R et al.International journal of immunotherapy. 1997, Vol 13, Num 1-2, pp 9-16, issn 0255-9625Article

Inhibition of PDGF-stimulated rat smooth muscle cell proliferation by MNA 279 and MNA 715CZECH, J; SCHWAB, W; SCHORLEMMER, H. U et al.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4197-4199, issn 0041-1345Conference Paper

Effects of the immunosuppressive malononitrilamides on rheumatoid and systemic lupus erythematosus (SLE)-like diseasesSCHORLEMMER, H. U; BARTLETT, R. R.International journal of immunotherapy. 1997, Vol 13, Num 1-2, pp 1-7, issn 0255-9625Article

Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE)SCHORLEMMER, H. U; BARTLETT, R. R.Drugs under experimental and clinical research. 1997, Vol 23, Num 5-6, pp 175-181, issn 0378-6501Article

Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS)SCHORLEMMER, H. U; SEILER, F. R.Drugs under experimental and clinical research. 1991, Vol 17, Num 10-11, pp 461-469, issn 0378-6501Article

Leflunomide's active metabolite A77-1726 and its derivatives, the malononitrilamides, inhibit the generation of oxygen radicals in mononuclear phagocytesSCHORLEMMER, H. U; KURRLE, R; SCHLEYERBACH, R et al.International journal of immunotherapy. 1998, Vol 14, Num 4, pp 213-222, issn 0255-9625Article

The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodentsSCHORLEMMER, H. U; KURRLE, R; BARTLETT, R. R et al.Drugs under experimental and clinical research. 1997, Vol 23, Num 5-6, pp 167-173, issn 0378-6501Article

Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualinSCHORLEMMER, H. U; DICKNEITE, G; SEILER, F. R et al.Transplantation proceedings. 1990, Vol 22, Num 4, pp 1626-1630, issn 0041-1345, 5 p.Conference Paper

Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophagesDICKNEITE, G; SCHORLEMMER, H. U; SEDLACK, H. H et al.International journal of immunopharmacology. 1989, Vol 11, Num 8, pp 895-903, issn 0192-0561Article

Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (±)-15-deoxyspergualinDICKNEITE, G; SCHORLEMMER, H. U; SEDLACEK, H. H et al.International journal of immunopharmacology. 1987, Vol 9, Num 5, pp 559-565, issn 0192-0561Article

Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes = Capacité pour la bestatine, dipeptide immunomodulateur, d'activer les phagocytes mononucléaires cytotoxiquesSCHORLEMMER, H. U; BOSSLET, K; SEDLACEK, H. H et al.Cancer research (Baltimore). 1983, Vol 43, Num 9, pp 4148-4153, issn 0008-5472Article

Inhibition of smooth muscle cell proliferation by A77-1726 and its derivatives can be antagonized by uridineCZECH, J; KURRLE, R; SCHORLEMMER, H. U et al.International journal of immunotherapy. 1998, Vol 14, Num 4, pp 185-191, issn 0255-9625Article

A77-1726, leflunomide's active metabolite, inhibits in vivo lymphoproliferation in the popliteal lymph node assaySCHORLEMMER, H. U; KURRLE, R; SCHLEYERBACH, R et al.International journal of immunotherapy. 1998, Vol 14, Num 4, pp 205-211, issn 0255-9625Article

Immunomodulatory activity of malononitrilamides, derivatives of leflunomide's primary metabolite, on models of experimental rheumatoid arthritisSCHORLEMMER, H. U; BARTLETT, R. R; SCHLEYERBACH, R et al.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4137-4139, issn 0041-1345Conference Paper

Curative effects of 15-deoxyspergualin on murine systemic lupus erythematosus-like disease in MRL/1 autoimmune miceSCHORLEMMER, H. U; BARTLETT, R. R; SEILER, F. R et al.International journal of immunotherapy. 1991, Vol 7, Num 4, pp 169-180, issn 0255-9625Article

Malononitrilamides inhibit the development of various murine graft-vs-host diseasesSCHORLEMMER, H. U; KURRLE, R; BARTLETT, R. R et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3043-3047, issn 0041-1345Conference Paper

Effect of malononitrilamides on human bone marrowCZECH, J; SCHORLEMMER, H. U; SCHWAB, W et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3051-3052, issn 0041-1345Conference Paper

Malononitrilamides prevent the development of murine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/Ipr autoimmune miceSCHORLEMMER, H. U; BRENDEL, S; BARTLETT, R. R et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3040-3042, issn 0041-1345Conference Paper

In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammationJOSEPH, K; HÖFFKEN, H; BOSSLET, K et al.European journal of nuclear medicine. 1988, Vol 14, Num 7-8, pp 367-373, issn 0340-6997Article

Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamidesSCHORLEMMER, H. U; KURRLE, R.Transplantation proceedings. 1998, Vol 30, Num 4, pp 963-967, issn 0041-1345Conference Paper

  • Page / 3